Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY

Am J Gastroenterol. 2008 Oct;103(10):2613-23. doi: 10.1111/j.1572-0241.2008.02041.x. Epub 2008 Sep 4.

Abstract

Background/objectives: In patients with functional dyspepsia (FD), symptoms are frequently triggered, or exacerbated, by fatty foods. We hypothesized that in FD patients, a high-fat (high-FAT) meal would induce more symptoms than a high-carbohydrate (high-CHO) meal, associated with an altered secretion of cholecystokinin (CCK), peptide-YY (PYY), and ghrelin and an increased antral size, when compared to healthy subjects (HS).

Methods: FD symptoms, appetite perceptions, plasma hormones, and antral area were measured in 8 FD patients and 8 HS on three separate days after the ingestion of high-CHO or high-FAT (500 kcal/400 g) meals, or a low-nutrient control (180 kcal/400 g); the energy intake was quantified 60 min later.

Results: Nausea (P < 0.01) and pain (P= 0.05) were greater in FD after the high-FAT, when compared to high-CHO and control meals and in HS. Discomfort was greater after all meals in FD when compared to HS (P < 0.05). Fasting CCK and stimulation of CCK by the high-FAT (P < 0.01) meal were greater in FD, while fasting and postprandial PYY were lower (P < 0.001) in FD than in HS, with no differences in fasting, or postprandial, plasma ghrelin between FD and HS. Fasting antral area was greater in FD (P < 0.05), with no differences postprandially between FD and HS. There were no differences in the energy intake between the two groups.

Conclusions: In FD patients: (a) a high-FAT meal induces more symptoms than an isocaloric high-CHO meal, and (b) fasting and postprandial plasma CCK concentrations are greater and PYY concentrations are less. Our findings have important implications for the development of diet-based therapies for the treatment of FD.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cholecystokinin / metabolism*
  • Dietary Carbohydrates / pharmacology*
  • Dietary Fats / therapeutic use*
  • Disease Progression
  • Dyspepsia / drug therapy*
  • Dyspepsia / metabolism
  • Dyspepsia / physiopathology
  • Fasting / physiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Peptide YY / metabolism*
  • Postprandial Period / physiology*
  • Prognosis
  • Surveys and Questionnaires

Substances

  • Dietary Carbohydrates
  • Dietary Fats
  • Peptide YY
  • Cholecystokinin